Evidence of increased oxidative stress is typically seen in the plasma and in the white adipose tissue of obese mice [80], in which the administration of ROS inhibitors improves hyperglycemia, hyperinsulinemia, and hyperlipidemia and reduces both ROS production and TNF-α expression [80]. The gene discussed is TNF; the disease is hyperlipidemia.